RGX-104

Overview

RGX-104 is an orally bioavailable and potent liver-X nuclear hormone receptor ( LXR ) agonist that modulates innate immunity via transcriptional activation of the ApoE gene.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > LXR

Product Information

• Catalog No.: HY-111498A
• CAS No.: 610318-54-2
• Molecular Formula: C34H33ClF3NO3
• Molecular Weight: 596.08
• Purity: 99.76%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.17 mg/mL (3.64 mM); Clear solution
• Availability: In-stock

Source

Original product source